Hervé Guillard
37Patents
16h-index
7Co-inventors
74Inventor score
Filing activity: May 17, 2001 → Sep 18, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10272062B2 | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics | Human Necessities | 59 | Active |
| US10736866B2 | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics | Human Necessities | 47 | Active |
| US10973795B2 | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics | Human Necessities | 42 | Active |
| US10952986B2 | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics | Human Necessities | 42 | Active |
| US11065224B2 | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics | Human Necessities | 35 | Active |
| US11504347B1 | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics | Human Necessities | 35 | Active |
| US11000498B2 | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics | Human Necessities | 34 | Active |
| US11583510B1 | Methods of administering gamma hydroxybutyrate formulations after a high-fat meal | Human Necessities | 34 | Active |
| US11602513B1 | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics | Human Necessities | 33 | Active |
| US11602512B1 | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics | Human Necessities | 33 | Active |
| US11052061B2 | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics | Human Necessities | 29 | Active |
| US11766418B2 | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics | Human Necessities | 24 | Active |
| US11826335B2 | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics | Human Necessities | 24 | Active |
| US11839597B2 | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics | Human Necessities | 24 | Active |
| US11896572B2 | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics | Human Necessities | 23 | Active |
| US11986451B1 | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics | Human Necessities | 22 | Active |
| US12128021B1 | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics | Human Necessities | 9 | Active |
| US12138239B2 | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics | Human Necessities | 7 | Active |
| US12115142B2 | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics | Human Necessities | 7 | Active |
| US12115144B2 | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics | Human Necessities | 7 | Active |
| US12115145B2 | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics | Human Necessities | 7 | Active |
| US12097175B2 | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics | Human Necessities | 7 | Active |
| US12115143B2 | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics | Human Necessities | 7 | Active |
| US7270769B2 | Precursor for preparing an optical material, method and optical components obtained with same and uses thereof | Chemistry; Metallurgy | 5 | Expired |
| US11779557B1 | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics | Human Necessities | 5 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.